Publications by authors named "R Balm"
Article Synopsis
- * Methods: Researchers reviewed data from patients who received VBX stent grafts during F/B-EVAR between January 2019 and May 2023, focusing on technical success, potential complications, and overall patient survival.
- * Results: The study found a 97.5% technical success rate for VBX stent graft implantation, with low rates of complications and high overall survival at 86.7% after
Article Synopsis
- The study aimed to identify factors that predict clinical success in invasive treatments for femoropopliteal disease to help guide medical decisions.
- A retrospective analysis was conducted on 676 patients who received either endovascular therapy (EVT) or femoropopliteal bypass (FPB), with key outcomes including clinical patency and amputation rates.
- Critical limb-threatening ischemia (CLTI) was found to negatively impact primary clinical patency, while factors like FPB surgery, higher ankle-brachial index, and more distal runoff vessels positively influenced secondary clinical patency.
Objective: Type 2 diabetes mellitus (T2DM) is a cardiovascular risk factor. Paradoxically, a decreased risk of abdominal aortic aneurysm (AAA) presence and growth rate is described among patients with T2DM, associated with metformin use. This study aimed to investigate the effect of metformin on AAA patient-derived aortic smooth muscle cell (SMC) function.
View Article and Find Full Text PDFIntroduction: The aim of this study is to share preliminary experiences and outcomes with a novel custom-made fenestrated TREO Abdominal Stent-Graft System to treat juxtarenal and pararenal abdominal aortic aneurysms (AAAs).
Methods: Juxtarenal and pararenal AAA patients treated with the custom-made fenestrated TREO Abdominal Stent-Graft System were included from 4 high-volume European academic medical centers from June 2021 to September 2023. Technical success and 30-day/in-hospital mortality and complications were analyzed.
The antibiotic doxycycline is known to inhibit inflammation and was therefore considered as a therapeutic to prevent abdominal aortic aneurysm (AAA) growth. Yet mitochondrial dysfunction is a key-characteristic of clinical AAA disease. We hypothesize that doxycycline impairs mitochondrial function in the aorta and aortic smooth muscle cells (SMCs).
View Article and Find Full Text PDF